MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
60 hedge funds and large institutions have $87M invested in Marinus Pharmaceuticals, Inc in 2018 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
-5
Holders Change %
-7.69%
% of All Funds
1.38%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
17
Increased
19
Reduced
14
Closed
21
Calls
$3.6M
Puts
$3.07M
Net Calls
+$535K
Net Calls Change
-$418K
Top Buyers
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
+$4.84M |
| 2 |
TBC
Three Bays Capital
Boston,
Massachusetts
|
+$3.61M |
| 3 |
6CM
683 Capital Management
New York
|
+$2.48M |
| 4 |
HT
HAP Trading
New York
|
+$1.45M |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$1.37M |
Top Sellers
| 1 |
AC
Ascend Capital
Orinda,
California
|
-$8.26M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.17M |
| 3 |
NC
Nexthera Capital
New York
|
-$7.55M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$7.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.63M |
